Corteva, Inc. (NYSE:CTVA - Get Free Report) announced a quarterly dividend on Tuesday, April 28th. Shareholders of record on Monday, June 1st will be paid a dividend of 0.18 per share on Monday, June 15th. This represents a c) annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, June 1st.
Corteva has raised its dividend payment by an average of 0.1%per year over the last three years and has increased its dividend every year for the last 5 years. Corteva has a payout ratio of 20.5% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Corteva to earn $3.98 per share next year, which means the company should continue to be able to cover its $0.72 annual dividend with an expected future payout ratio of 18.1%.
Corteva Stock Performance
Corteva stock traded down $0.48 during mid-day trading on Tuesday, hitting $78.95. 2,569,013 shares of the company's stock traded hands, compared to its average volume of 4,007,005. The firm has a 50 day simple moving average of $80.19 and a two-hundred day simple moving average of $71.82. Corteva has a fifty-two week low of $60.53 and a fifty-two week high of $85.63. The stock has a market cap of $53.00 billion, a price-to-earnings ratio of 49.97, a P/E/G ratio of 2.74 and a beta of 0.68. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96.
Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter last year, the firm posted $0.32 EPS. The company's quarterly revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts expect that Corteva will post 3.62 EPS for the current fiscal year.
Insiders Place Their Bets
In other Corteva news, insider Brian Titus sold 8,311 shares of the stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider owned 8,090 shares in the company, valued at $619,289.50. This trade represents a 50.67% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.15% of the stock is owned by insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of CTVA. Activest Wealth Management increased its position in shares of Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company's stock worth $25,000 after purchasing an additional 200 shares during the period. JPL Wealth Management LLC bought a new position in shares of Corteva in the third quarter worth $25,000. True Wealth Design LLC increased its position in shares of Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company's stock worth $26,000 after purchasing an additional 264 shares during the period. Garton & Associates Financial Advisors LLC bought a new position in shares of Corteva in the fourth quarter worth $27,000. Finally, Bank of Jackson Hole Trust bought a new position in shares of Corteva in the fourth quarter worth $28,000. Institutional investors own 81.54% of the company's stock.
About Corteva
(
Get Free Report)
Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.